These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30397056)

  • 1.
    Karlowsky JA; Adam HJ; Baxter MR; Denisuik AJ; Lagacé-Wiens PRS; Walkty AJ; Puttagunta S; Dunne MW; Zhanel GG
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program.
    Maher JM; Huband MD; Blankers CG; Puttagunta S; Aronin SI; Castanheira M
    J Antimicrob Chemother; 2023 Jun; 78(6):1406-1414. PubMed ID: 37042351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin and co-trimoxazole resistance and extended spectrum beta-lactamase production in Escherichia coli strains isolated from urinary tract infections.
    Ozden M; Kalkan A; Demirdag K; Kilic SS; Ozdarendeli A
    Int J Antimicrob Agents; 2003 May; 21(5):492-3. PubMed ID: 12727086
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro susceptibility of urinary Escherichia coli isolates to first- and second-line empirically prescribed oral antimicrobials: CANWARD surveillance study results for Canadian outpatients, 2007-2016.
    Karlowsky JA; Lagacé-Wiens PRS; Adam HJ; Baxter MR; Laing NM; Walkty AJ; Zhanel GG
    Int J Antimicrob Agents; 2019 Jul; 54(1):62-68. PubMed ID: 31034938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of sulopenem against 1880 bacterial pathogens isolated from Canadian patients with urinary tract infections (CANWARD, 2014-21).
    Walkty AJ; Karlowsky JA; Baxter MR; Lagace-Wiens PRS; Adam HJ; Zhanel GG
    J Antimicrob Chemother; 2022 Nov; 77(12):3414-3420. PubMed ID: 36177825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City.
    Arredondo-García JL; Amábile-Cuevas CF
    J Infect Dev Ctries; 2008 Oct; 2(5):350-3. PubMed ID: 19745501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection and persistence of antimicrobial-resistant Escherichia coli including extended-spectrum β-lactamase producers in different poultry flocks on one chicken farm.
    Schwaiger K; Bauer J; Hölzel CS
    Microb Drug Resist; 2013 Dec; 19(6):498-506. PubMed ID: 23844850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae].
    de Cueto M; Hernández JR; López-Cerero L; Morillo C; Pascual A
    Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):613-6. PubMed ID: 17194386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada--results of the CANWARD 2007-2009 study.
    Lagacé-Wiens PR; Simner PJ; Forward KR; Tailor F; Adam HJ; Decorby M; Karlowsky J; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):314-9. PubMed ID: 21353959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
    Karlowsky JA; Hoban DJ; Decorby MR; Laing NM; Zhanel GG
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2251-4. PubMed ID: 16723598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of Eravacycline against Escherichia coli Clinical Isolates Collected from U.S. Veterans in 2011 in Relation to Coresistance Phenotype and Sequence Type 131 Genotype.
    Johnson JR; Porter SB; Johnston BD; Thuras P
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1888-91. PubMed ID: 26666925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
    Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Class 1 Integrons and Extended Spectrum Beta Lactamases among Multi-Drug Resistant Escherichia coli Isolates from North of Iran.
    Mehdipour Moghaddam MJ; Mirbagheri AA; Salehi Z; Habibzade SM
    Iran Biomed J; 2015; 19(4):233-9. PubMed ID: 26220727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae.
    So W; Crandon JL; Nicolau DP
    J Urol; 2015 Aug; 194(2):563-70. PubMed ID: 25637857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
    Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
    Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of fosfomycin resistance among isolates of Escherichia coli harboring extended-spectrum and AmpC β-lactamases.
    Bahramian A; Eslami G; Hashemi A; Tabibi A; Heidary M
    Acta Microbiol Immunol Hung; 2018 Mar; 65(1):15-25. PubMed ID: 29137487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
    Sanchez GV; Baird AM; Karlowsky JA; Master RN; Bordon JM
    J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.
    Can F; Azap OK; Seref C; Ispir P; Arslan H; Ergonul O
    Clin Infect Dis; 2015 Feb; 60(4):523-7. PubMed ID: 25378460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].
    Rodríguez-Avial C; Rodríguez-Avial I; Hernández E; Picazo JJ
    Rev Esp Quimioter; 2013 Mar; 26(1):43-6. PubMed ID: 23546462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.